Megan A Lewis1, Laura K Wagner2, Lisa G Rosas3, Nan Lv4, Elizabeth M Venditti5, Lesley E Steinman6, Bryan J Weiner7,8, Jeremy D Goldhaber-Fiebert9, Mark B Snowden10, Jun Ma4,11. 1. Center for Communication Science, RTI International, Seattle, WA, United States of America. 2. Center for Communication Science, RTI International, Research Triangle Park, NC, United States of America. 3. Department of Epidemiology and Population Health, Stanford School of Medicine, Palo Alto, CA, United States of America. 4. Institute of Health Research and Policy, University of Illinois at Chicago, Chicago, IL, United States of America. 5. Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States of America. 6. Health Promotion Research Center, University of Washington, Seattle, WA, United States of America. 7. Department of Global Health, University of Washington, Seattle, WA, United States of America. 8. Department of Health Services, University of Washington, Seattle, WA, United States of America. 9. Stanford Health Policy, Centers for Health Policy and Primary Care and Outcomes Research, Stanford University, Palo Alto, CA, United States of America. 10. Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington, Seattle, WA, United States of America. 11. Department of Medicine, College of Medicine, University of Illinois at Chicago, Chicago, IL, United States of America.
Abstract
BACKGROUND: An integrated collaborative care intervention was used to treat primary care patients with comorbid obesity and depression in a randomized clinical trial. To increase wider uptake and dissemination, information is needed on translational potential. METHODS: The trial collected longitudinal, qualitative data at baseline, 6 months (end of intensive treatment), 12 months (end of maintenance treatment), and 24 months (end of follow-up). Semi-structured interviews (n = 142) were conducted with 54 out of 409 randomly selected trial participants and 37 other stakeholders, such as recruitment staff, intervention staff, and clinicians. Using a Framework Analysis approach, we examined themes across time and stakeholder groups according to the RE-AIM (Reach, Effectiveness, Adoption, Implementation, and Maintenance) framework. RESULTS: At baseline, participants and other stakeholders reported being skeptical of the collaborative care approach related to some RE-AIM dimensions. However, over time they indicated greater confidence regarding the potential for future public health impact. They also provided information on barriers and actionable information to enhance program reach, effectiveness, adoption, implementation, and maintenance. CONCLUSIONS: RE-AIM provided a useful framework for understanding how to increase the impact of a collaborative and integrative approach for treating comorbid obesity and depression. It also demonstrates the utility of using the framework as a planning tool early in the evidence-generation pipeline.
RCT Entities:
BACKGROUND: An integrated collaborative care intervention was used to treat primary care patients with comorbid obesity and depression in a randomized clinical trial. To increase wider uptake and dissemination, information is needed on translational potential. METHODS: The trial collected longitudinal, qualitative data at baseline, 6 months (end of intensive treatment), 12 months (end of maintenance treatment), and 24 months (end of follow-up). Semi-structured interviews (n = 142) were conducted with 54 out of 409 randomly selected trial participants and 37 other stakeholders, such as recruitment staff, intervention staff, and clinicians. Using a Framework Analysis approach, we examined themes across time and stakeholder groups according to the RE-AIM (Reach, Effectiveness, Adoption, Implementation, and Maintenance) framework. RESULTS: At baseline, participants and other stakeholders reported being skeptical of the collaborative care approach related to some RE-AIM dimensions. However, over time they indicated greater confidence regarding the potential for future public health impact. They also provided information on barriers and actionable information to enhance program reach, effectiveness, adoption, implementation, and maintenance. CONCLUSIONS: RE-AIM provided a useful framework for understanding how to increase the impact of a collaborative and integrative approach for treating comorbid obesity and depression. It also demonstrates the utility of using the framework as a planning tool early in the evidence-generation pipeline.
Authors: Jeremy D Goldhaber-Fiebert; Lea Prince; Lan Xiao; Nan Lv; Lisa G Rosas; Elizabeth M Venditti; Megan A Lewis; Mark B Snowden; Jun Ma Journal: Obesity (Silver Spring) Date: 2020-04-22 Impact factor: 5.002
Authors: Ross C Brownson; Julie A Jacobs; Rachel G Tabak; Christine M Hoehner; Katherine A Stamatakis Journal: Am J Public Health Date: 2013-07-18 Impact factor: 9.308
Authors: Matthew J Press; Ryan Howe; Michael Schoenbaum; Sean Cavanaugh; Ann Marshall; Lindsey Baldwin; Patrick H Conway Journal: N Engl J Med Date: 2016-12-14 Impact factor: 91.245
Authors: Jun Ma; Lisa Goldman Rosas; Nan Lv; Lan Xiao; Mark B Snowden; Elizabeth M Venditti; Megan A Lewis; Jeremy D Goldhaber-Fiebert; Philip W Lavori Journal: JAMA Date: 2019-03-05 Impact factor: 56.272
Authors: Floriana S Luppino; Leonore M de Wit; Paul F Bouvy; Theo Stijnen; Pim Cuijpers; Brenda W J H Penninx; Frans G Zitman Journal: Arch Gen Psychiatry Date: 2010-03
Authors: Emile Pereira-Miranda; Priscila R F Costa; Valterlinda A O Queiroz; Marcos Pereira-Santos; Mônica L P Santana Journal: J Am Coll Nutr Date: 2017-04-10 Impact factor: 3.169
Authors: M Kaye Kramer; Andrea M Kriska; Elizabeth M Venditti; Rachel G Miller; Maria M Brooks; Lora E Burke; Linda M Siminerio; Francis X Solano; Trevor J Orchard Journal: Am J Prev Med Date: 2009-12 Impact factor: 5.043
Authors: Elizabeth M Venditti; Lesley E Steinman; Megan A Lewis; Bryan J Weiner; Jun Ma Journal: Transl Behav Med Date: 2021-09-15 Impact factor: 3.046